Loading…
Assessment of Residual Viability by Enoximone Echocardiography in Patients with Previous Myocardial Infarction Correlation with Positron Emission Tomographic Studies and Functional Follow-Up
Background: The aim of this study was to evaluate enoximone echocardiography (EE) for the identification of residual myocardial viability in postinfarction patients. Findings obtained during EE were compared with those acquired by myocardial uptake of fluorine‐18 fluorodeoxyglucose (18F‐FDG) positro...
Saved in:
Published in: | Echocardiography (Mount Kisco, N.Y.) N.Y.), 2010-05, Vol.27 (5), p.544-551 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c3522-558c85ba4a9671953a00f74b0cf8f49ee140c132fa142e7bd3ae3d86467b4ae33 |
container_end_page | 551 |
container_issue | 5 |
container_start_page | 544 |
container_title | Echocardiography (Mount Kisco, N.Y.) |
container_volume | 27 |
creator | Lu, Fei Carlino, Mauro Lu, Chunzeng Landoni, Claudio Lucignani, Giovanni Fragasso, Gabriele Di Bello, Vitantonio Margonato, Alberto Chierchia, Sergio L. Marzilli, Mario Balbarini, Alberto |
description | Background: The aim of this study was to evaluate enoximone echocardiography (EE) for the identification of residual myocardial viability in postinfarction patients. Findings obtained during EE were compared with those acquired by myocardial uptake of fluorine‐18 fluorodeoxyglucose (18F‐FDG) positron emission tomography (PET) and functional follow‐up results. Methods: Twenty‐five patients underwent EE and PET 18F‐FDG studies. An asynergic segment was considered as having contractile enhancement when the wall motion score decreased by ≥1 grade during EE and was defined as viable if 18F‐FDG uptake score was ≥2 grade on PET. Results: Of 293 dysfunctional segments at baseline, 139 (47%) were viable by PET criteria; 117 (40%) had contractile enhancement induced by enoximone (P = 0.07). Agreement between EE and PET was found in 75% of involved segments (K = 0.46, P < 0.001). The majority of discrepancies (65%, P < 0.01) were mainly due to discordant segments in which PET revealed evidence of 18F‐FDG uptake but EE showed no change in wall motion. In 179 revascularized segments, negative predictive value for functional recovery of both tests reached the same value (89% for both), whereas positive predictive value was 82% for EE and 68% for PET, respectively (P < 0.05). Sensitivity was 85% for EE and 88% for PET (P = ns); specificity was 87% and 70%, respectively (P < 0.01). Conclusions: EE yields a fair concordance with PET study. Compared with PET, despite a similar negative accuracy, EE shows a greater specificity for prediction of function recovery after revascularization. (Echocardiography 2010;27:544‐551) |
doi_str_mv | 10.1111/j.1540-8175.2009.01082.x |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733649513</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733649513</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3522-558c85ba4a9671953a00f74b0cf8f49ee140c132fa142e7bd3ae3d86467b4ae33</originalsourceid><addsrcrecordid>eNqNkctu1DAUhq0K1E4Lr4C8Y5XgW24bpDLKtJV6GWhLERvLcRzGQxIPdtKZvFyfDWdSZo03Psfn_z_b-gGAGIXYr0_rEEcMBSlOopAglIUIo5SEuyMwOwzegBlKGAlISsgJOHVujRBKMGbH4IQg6kdxMgMv584p5xrVdtBU8JtyuuxFDb9rUehadwMsBpi3Zqcb0yqYy5WRwpba_LJisxqgbuFSdNrbHdzqbgWXVj1r0zt4M0xKD7tqK2Flp00L58ZaVYt9PemN0531Xd5o58bjB9NMdC3hfdeXWjko2hIu-nbP8MCFqWuzDR4378DbStROvX_dz8DjIn-YXwbXdxdX8_PrQNKIkCCKUplGhWAiixOcRVQgVCWsQLJKK5YphRmSmJJKYEZUUpRUKFqmMYuTgvmSnoGPE3djzZ9euY7710pV16JV_rM8oTRmWYRHZToppTXOWVXxjdWNsAPHiI_h8TUfM-JjRnwMj-_D4ztv_fB6SV80qjwY_6XlBZ8nwVbXavhvMM_nl3dj6QHBBNCuU7sDQNjf3OO97en2gtOnrz-X97c_-Bf6Fx4QvRw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733649513</pqid></control><display><type>article</type><title>Assessment of Residual Viability by Enoximone Echocardiography in Patients with Previous Myocardial Infarction Correlation with Positron Emission Tomographic Studies and Functional Follow-Up</title><source>Wiley-Blackwell Journals</source><creator>Lu, Fei ; Carlino, Mauro ; Lu, Chunzeng ; Landoni, Claudio ; Lucignani, Giovanni ; Fragasso, Gabriele ; Di Bello, Vitantonio ; Margonato, Alberto ; Chierchia, Sergio L. ; Marzilli, Mario ; Balbarini, Alberto</creator><creatorcontrib>Lu, Fei ; Carlino, Mauro ; Lu, Chunzeng ; Landoni, Claudio ; Lucignani, Giovanni ; Fragasso, Gabriele ; Di Bello, Vitantonio ; Margonato, Alberto ; Chierchia, Sergio L. ; Marzilli, Mario ; Balbarini, Alberto</creatorcontrib><description>Background: The aim of this study was to evaluate enoximone echocardiography (EE) for the identification of residual myocardial viability in postinfarction patients. Findings obtained during EE were compared with those acquired by myocardial uptake of fluorine‐18 fluorodeoxyglucose (18F‐FDG) positron emission tomography (PET) and functional follow‐up results. Methods: Twenty‐five patients underwent EE and PET 18F‐FDG studies. An asynergic segment was considered as having contractile enhancement when the wall motion score decreased by ≥1 grade during EE and was defined as viable if 18F‐FDG uptake score was ≥2 grade on PET. Results: Of 293 dysfunctional segments at baseline, 139 (47%) were viable by PET criteria; 117 (40%) had contractile enhancement induced by enoximone (P = 0.07). Agreement between EE and PET was found in 75% of involved segments (K = 0.46, P < 0.001). The majority of discrepancies (65%, P < 0.01) were mainly due to discordant segments in which PET revealed evidence of 18F‐FDG uptake but EE showed no change in wall motion. In 179 revascularized segments, negative predictive value for functional recovery of both tests reached the same value (89% for both), whereas positive predictive value was 82% for EE and 68% for PET, respectively (P < 0.05). Sensitivity was 85% for EE and 88% for PET (P = ns); specificity was 87% and 70%, respectively (P < 0.01). Conclusions: EE yields a fair concordance with PET study. Compared with PET, despite a similar negative accuracy, EE shows a greater specificity for prediction of function recovery after revascularization. (Echocardiography 2010;27:544‐551)</description><identifier>ISSN: 0742-2822</identifier><identifier>EISSN: 1540-8175</identifier><identifier>DOI: 10.1111/j.1540-8175.2009.01082.x</identifier><identifier>PMID: 20374267</identifier><language>eng</language><publisher>Malden, USA: Blackwell Publishing Inc</publisher><subject>Aged ; Coronary Angiography ; echocardiography ; Echocardiography - methods ; Enoximone ; Female ; Fluorodeoxyglucose F18 ; Hemodynamics ; Humans ; Image Interpretation, Computer-Assisted ; Male ; Middle Aged ; Myocardial Contraction ; Myocardial Infarction - diagnostic imaging ; Myocardial Infarction - physiopathology ; Myocardial Revascularization ; myocardial viability ; Positron-Emission Tomography ; Predictive Value of Tests ; Radiopharmaceuticals ; Vasodilator Agents</subject><ispartof>Echocardiography (Mount Kisco, N.Y.), 2010-05, Vol.27 (5), p.544-551</ispartof><rights>2010, the Authors Journal compilation © 2010, Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3522-558c85ba4a9671953a00f74b0cf8f49ee140c132fa142e7bd3ae3d86467b4ae33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1540-8175.2009.01082.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1540-8175.2009.01082.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,786,790,27957,27958,50923,51032</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20374267$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lu, Fei</creatorcontrib><creatorcontrib>Carlino, Mauro</creatorcontrib><creatorcontrib>Lu, Chunzeng</creatorcontrib><creatorcontrib>Landoni, Claudio</creatorcontrib><creatorcontrib>Lucignani, Giovanni</creatorcontrib><creatorcontrib>Fragasso, Gabriele</creatorcontrib><creatorcontrib>Di Bello, Vitantonio</creatorcontrib><creatorcontrib>Margonato, Alberto</creatorcontrib><creatorcontrib>Chierchia, Sergio L.</creatorcontrib><creatorcontrib>Marzilli, Mario</creatorcontrib><creatorcontrib>Balbarini, Alberto</creatorcontrib><title>Assessment of Residual Viability by Enoximone Echocardiography in Patients with Previous Myocardial Infarction Correlation with Positron Emission Tomographic Studies and Functional Follow-Up</title><title>Echocardiography (Mount Kisco, N.Y.)</title><addtitle>Echocardiography</addtitle><description>Background: The aim of this study was to evaluate enoximone echocardiography (EE) for the identification of residual myocardial viability in postinfarction patients. Findings obtained during EE were compared with those acquired by myocardial uptake of fluorine‐18 fluorodeoxyglucose (18F‐FDG) positron emission tomography (PET) and functional follow‐up results. Methods: Twenty‐five patients underwent EE and PET 18F‐FDG studies. An asynergic segment was considered as having contractile enhancement when the wall motion score decreased by ≥1 grade during EE and was defined as viable if 18F‐FDG uptake score was ≥2 grade on PET. Results: Of 293 dysfunctional segments at baseline, 139 (47%) were viable by PET criteria; 117 (40%) had contractile enhancement induced by enoximone (P = 0.07). Agreement between EE and PET was found in 75% of involved segments (K = 0.46, P < 0.001). The majority of discrepancies (65%, P < 0.01) were mainly due to discordant segments in which PET revealed evidence of 18F‐FDG uptake but EE showed no change in wall motion. In 179 revascularized segments, negative predictive value for functional recovery of both tests reached the same value (89% for both), whereas positive predictive value was 82% for EE and 68% for PET, respectively (P < 0.05). Sensitivity was 85% for EE and 88% for PET (P = ns); specificity was 87% and 70%, respectively (P < 0.01). Conclusions: EE yields a fair concordance with PET study. Compared with PET, despite a similar negative accuracy, EE shows a greater specificity for prediction of function recovery after revascularization. (Echocardiography 2010;27:544‐551)</description><subject>Aged</subject><subject>Coronary Angiography</subject><subject>echocardiography</subject><subject>Echocardiography - methods</subject><subject>Enoximone</subject><subject>Female</subject><subject>Fluorodeoxyglucose F18</subject><subject>Hemodynamics</subject><subject>Humans</subject><subject>Image Interpretation, Computer-Assisted</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Myocardial Contraction</subject><subject>Myocardial Infarction - diagnostic imaging</subject><subject>Myocardial Infarction - physiopathology</subject><subject>Myocardial Revascularization</subject><subject>myocardial viability</subject><subject>Positron-Emission Tomography</subject><subject>Predictive Value of Tests</subject><subject>Radiopharmaceuticals</subject><subject>Vasodilator Agents</subject><issn>0742-2822</issn><issn>1540-8175</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNqNkctu1DAUhq0K1E4Lr4C8Y5XgW24bpDLKtJV6GWhLERvLcRzGQxIPdtKZvFyfDWdSZo03Psfn_z_b-gGAGIXYr0_rEEcMBSlOopAglIUIo5SEuyMwOwzegBlKGAlISsgJOHVujRBKMGbH4IQg6kdxMgMv584p5xrVdtBU8JtyuuxFDb9rUehadwMsBpi3Zqcb0yqYy5WRwpba_LJisxqgbuFSdNrbHdzqbgWXVj1r0zt4M0xKD7tqK2Flp00L58ZaVYt9PemN0531Xd5o58bjB9NMdC3hfdeXWjko2hIu-nbP8MCFqWuzDR4378DbStROvX_dz8DjIn-YXwbXdxdX8_PrQNKIkCCKUplGhWAiixOcRVQgVCWsQLJKK5YphRmSmJJKYEZUUpRUKFqmMYuTgvmSnoGPE3djzZ9euY7710pV16JV_rM8oTRmWYRHZToppTXOWVXxjdWNsAPHiI_h8TUfM-JjRnwMj-_D4ztv_fB6SV80qjwY_6XlBZ8nwVbXavhvMM_nl3dj6QHBBNCuU7sDQNjf3OO97en2gtOnrz-X97c_-Bf6Fx4QvRw</recordid><startdate>201005</startdate><enddate>201005</enddate><creator>Lu, Fei</creator><creator>Carlino, Mauro</creator><creator>Lu, Chunzeng</creator><creator>Landoni, Claudio</creator><creator>Lucignani, Giovanni</creator><creator>Fragasso, Gabriele</creator><creator>Di Bello, Vitantonio</creator><creator>Margonato, Alberto</creator><creator>Chierchia, Sergio L.</creator><creator>Marzilli, Mario</creator><creator>Balbarini, Alberto</creator><general>Blackwell Publishing Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201005</creationdate><title>Assessment of Residual Viability by Enoximone Echocardiography in Patients with Previous Myocardial Infarction Correlation with Positron Emission Tomographic Studies and Functional Follow-Up</title><author>Lu, Fei ; Carlino, Mauro ; Lu, Chunzeng ; Landoni, Claudio ; Lucignani, Giovanni ; Fragasso, Gabriele ; Di Bello, Vitantonio ; Margonato, Alberto ; Chierchia, Sergio L. ; Marzilli, Mario ; Balbarini, Alberto</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3522-558c85ba4a9671953a00f74b0cf8f49ee140c132fa142e7bd3ae3d86467b4ae33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Aged</topic><topic>Coronary Angiography</topic><topic>echocardiography</topic><topic>Echocardiography - methods</topic><topic>Enoximone</topic><topic>Female</topic><topic>Fluorodeoxyglucose F18</topic><topic>Hemodynamics</topic><topic>Humans</topic><topic>Image Interpretation, Computer-Assisted</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Myocardial Contraction</topic><topic>Myocardial Infarction - diagnostic imaging</topic><topic>Myocardial Infarction - physiopathology</topic><topic>Myocardial Revascularization</topic><topic>myocardial viability</topic><topic>Positron-Emission Tomography</topic><topic>Predictive Value of Tests</topic><topic>Radiopharmaceuticals</topic><topic>Vasodilator Agents</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lu, Fei</creatorcontrib><creatorcontrib>Carlino, Mauro</creatorcontrib><creatorcontrib>Lu, Chunzeng</creatorcontrib><creatorcontrib>Landoni, Claudio</creatorcontrib><creatorcontrib>Lucignani, Giovanni</creatorcontrib><creatorcontrib>Fragasso, Gabriele</creatorcontrib><creatorcontrib>Di Bello, Vitantonio</creatorcontrib><creatorcontrib>Margonato, Alberto</creatorcontrib><creatorcontrib>Chierchia, Sergio L.</creatorcontrib><creatorcontrib>Marzilli, Mario</creatorcontrib><creatorcontrib>Balbarini, Alberto</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Echocardiography (Mount Kisco, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lu, Fei</au><au>Carlino, Mauro</au><au>Lu, Chunzeng</au><au>Landoni, Claudio</au><au>Lucignani, Giovanni</au><au>Fragasso, Gabriele</au><au>Di Bello, Vitantonio</au><au>Margonato, Alberto</au><au>Chierchia, Sergio L.</au><au>Marzilli, Mario</au><au>Balbarini, Alberto</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Assessment of Residual Viability by Enoximone Echocardiography in Patients with Previous Myocardial Infarction Correlation with Positron Emission Tomographic Studies and Functional Follow-Up</atitle><jtitle>Echocardiography (Mount Kisco, N.Y.)</jtitle><addtitle>Echocardiography</addtitle><date>2010-05</date><risdate>2010</risdate><volume>27</volume><issue>5</issue><spage>544</spage><epage>551</epage><pages>544-551</pages><issn>0742-2822</issn><eissn>1540-8175</eissn><notes>istex:93B5591DEAF880D20E9D410FE16F5C21891780CA</notes><notes>ArticleID:ECHO1082</notes><notes>ark:/67375/WNG-3WQZPSNX-B</notes><notes>ObjectType-Article-1</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-2</notes><notes>content type line 23</notes><abstract>Background: The aim of this study was to evaluate enoximone echocardiography (EE) for the identification of residual myocardial viability in postinfarction patients. Findings obtained during EE were compared with those acquired by myocardial uptake of fluorine‐18 fluorodeoxyglucose (18F‐FDG) positron emission tomography (PET) and functional follow‐up results. Methods: Twenty‐five patients underwent EE and PET 18F‐FDG studies. An asynergic segment was considered as having contractile enhancement when the wall motion score decreased by ≥1 grade during EE and was defined as viable if 18F‐FDG uptake score was ≥2 grade on PET. Results: Of 293 dysfunctional segments at baseline, 139 (47%) were viable by PET criteria; 117 (40%) had contractile enhancement induced by enoximone (P = 0.07). Agreement between EE and PET was found in 75% of involved segments (K = 0.46, P < 0.001). The majority of discrepancies (65%, P < 0.01) were mainly due to discordant segments in which PET revealed evidence of 18F‐FDG uptake but EE showed no change in wall motion. In 179 revascularized segments, negative predictive value for functional recovery of both tests reached the same value (89% for both), whereas positive predictive value was 82% for EE and 68% for PET, respectively (P < 0.05). Sensitivity was 85% for EE and 88% for PET (P = ns); specificity was 87% and 70%, respectively (P < 0.01). Conclusions: EE yields a fair concordance with PET study. Compared with PET, despite a similar negative accuracy, EE shows a greater specificity for prediction of function recovery after revascularization. (Echocardiography 2010;27:544‐551)</abstract><cop>Malden, USA</cop><pub>Blackwell Publishing Inc</pub><pmid>20374267</pmid><doi>10.1111/j.1540-8175.2009.01082.x</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0742-2822 |
ispartof | Echocardiography (Mount Kisco, N.Y.), 2010-05, Vol.27 (5), p.544-551 |
issn | 0742-2822 1540-8175 |
language | eng |
recordid | cdi_proquest_miscellaneous_733649513 |
source | Wiley-Blackwell Journals |
subjects | Aged Coronary Angiography echocardiography Echocardiography - methods Enoximone Female Fluorodeoxyglucose F18 Hemodynamics Humans Image Interpretation, Computer-Assisted Male Middle Aged Myocardial Contraction Myocardial Infarction - diagnostic imaging Myocardial Infarction - physiopathology Myocardial Revascularization myocardial viability Positron-Emission Tomography Predictive Value of Tests Radiopharmaceuticals Vasodilator Agents |
title | Assessment of Residual Viability by Enoximone Echocardiography in Patients with Previous Myocardial Infarction Correlation with Positron Emission Tomographic Studies and Functional Follow-Up |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-23T02%3A17%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Assessment%20of%20Residual%20Viability%20by%20Enoximone%20Echocardiography%20in%20Patients%20with%20Previous%20Myocardial%20Infarction%20Correlation%20with%20Positron%20Emission%20Tomographic%20Studies%20and%20Functional%20Follow-Up&rft.jtitle=Echocardiography%20(Mount%20Kisco,%20N.Y.)&rft.au=Lu,%20Fei&rft.date=2010-05&rft.volume=27&rft.issue=5&rft.spage=544&rft.epage=551&rft.pages=544-551&rft.issn=0742-2822&rft.eissn=1540-8175&rft_id=info:doi/10.1111/j.1540-8175.2009.01082.x&rft_dat=%3Cproquest_cross%3E733649513%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3522-558c85ba4a9671953a00f74b0cf8f49ee140c132fa142e7bd3ae3d86467b4ae33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=733649513&rft_id=info:pmid/20374267&rfr_iscdi=true |